Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 758 across all filing types
Latest filing 2026-03-06 Regulatory Filings
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Złożenie do FDA wniosku pre-submission (Q-Sub) w projekcie AtriClamp - Content (EN)
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a regulatory submission (FDA Q-Submission) for a specific project (AtriClamp). It does not contain full financial statements, audit reports, or governance details, but rather serves as a notification of a regulatory event. Since it is a specific regulatory update that does not fit into other categories like M&A or share issues, it falls under the general regulatory filing category.
2026-03-06 English
Złożenie do FDA wniosku pre-submission (Q-Sub) w projekcie AtriClamp - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement from Medinice S.A. regarding a regulatory filing (pre-submission request) made to the US FDA for their AtriClamp project. It does not contain full financial statements, audit reports, or proxy materials. As it is a specific regulatory update regarding a company project and does not fit into the other specialized categories like M&A or share issues, it is best classified as a general regulatory filing.
2026-03-06 Polish
Oświadczenie KDPW w sprawie zawarcia z Emitentem umowy o rejestrację w depozycie papierów wartościowych akcji serii N, L2, L3. - Content (EN)
Share Issue/Capital Change Classification · 95% confidence The document announces the registration of new ordinary bearer shares (series N, L2, and L3) in the Central Securities Depository of Poland (CSDP). This relates to the issuance and registration of new capital/shares, which falls under the category of share issues or capital changes.
2026-02-27 English
Oświadczenie KDPW w sprawie zawarcia z Emitentem umowy o rejestrację w depozycie papierów wartościowych akcji serii N, L2, L3. - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory announcement from Medinice S.A. regarding the registration of new shares (Series N, L2, and L3) with the Central Securities Depository of Poland (KDPW). This constitutes a formal notification of a capital change and the issuance of new shares, which falls under the category of Share Issue/Capital Change.
2026-02-27 Polish
Formularz MAR Art. 19 ust. 3
Director's Dealing Classification · 100% confidence The document is a standard notification of transactions by persons discharging managerial responsibilities (PDMR) or persons closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details specific share disposals by 'ParmaNand Fundacja Rodzinna', which is identified as being closely associated with the CEO of Medinice S.A. This falls directly under the definition of Director's Dealing (DIRS).
2026-02-20 Polish
Otrzymanie zawiadomienia sporządzonego na podstawie art. 19 rozporządzenia MAR - Content (EN)
Director's Dealing Classification · 100% confidence The document is a short notification regarding a transaction in the company's shares by a person closely associated with the President of the Management Board. It explicitly references Article 19 of the MAR Regulation, which governs notifications of transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. This is a classic Director's Dealing or insider transaction report.
2026-02-20 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.